ahlam1399
09-02-2015, 07:25 PM
Gilead combo HIV pill matches Truvada efficacy but safer in trial
(Reuters) - Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function.
http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2.img (http://da.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/ach.img (http://adchoice.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/ach.htm)http://pi.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4982cb1b/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=dqIK0xbU5TA:zU0lVr-a5HE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=dqIK0xbU5TA:zU0lVr-a5HE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=dqIK0xbU5TA:zU0lVr-a5HE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=dqIK0xbU5TA:zU0lVr-a5HE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=dqIK0xbU5TA:zU0lVr-a5HE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/dqIK0xbU5TA
(Reuters) - Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function.
http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2.img (http://da.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/ach.img (http://adchoice.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/ach.htm)http://pi.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238385100691/u/49/f/654207/c/35217/s/4982cb1b/sc/14/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4982cb1b/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=dqIK0xbU5TA:zU0lVr-a5HE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=dqIK0xbU5TA:zU0lVr-a5HE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=dqIK0xbU5TA:zU0lVr-a5HE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=dqIK0xbU5TA:zU0lVr-a5HE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=dqIK0xbU5TA:zU0lVr-a5HE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/dqIK0xbU5TA